Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Colorectal Neoplasms

  Free Subscription


1 Adv Exp Med Biol
1 Am J Clin Oncol
1 Ann Oncol
4 Anticancer Res
1 BMC Cancer
1 Br J Surg
2 Clin Cancer Res
1 Dis Colon Rectum
3 Gastrointest Endosc
2 Hum Pathol
2 Int J Cancer
1 Int J Oncol
1 J Surg Oncol
1 Lancet Oncol
1 Oncol Rep
8 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Adv Exp Med Biol

  1. BANERJEE A, Chabria Y, Kanna N R R, Gopi J, et al
    Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment.
    Adv Exp Med Biol. 2019 Apr 11. doi: 10.1007/5584_2019.
    PubMed     Text format     Abstract available

    Am J Clin Oncol

  2. ALI ND, Donohue K, Zandieh S, Chen C, et al
    Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living >/=24 Months: A Single Institutional Study.
    Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000535.
    PubMed     Text format     Abstract available

    Ann Oncol

  3. SCHOU JV, Larsen FO, Sorensen BS, Abrantes R, et al
    Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
    Ann Oncol. 2018;29:610-615.
    PubMed     Text format     Abstract available

    Anticancer Res

  4. RALLIS G, Koletsa T, Saridaki Z, Manousou K, et al
    Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.
    Anticancer Res. 2019;39:2129-2138.
    PubMed     Text format     Abstract available

  5. HAMADA K, Otsubo R, Takeshita H, Nonaka T, et al
    Diagnosis of Lymph Node Metastasis in Colorectal Cancer by a Semi-dry Dot-blot Method.
    Anticancer Res. 2019;39:2069-2076.
    PubMed     Text format     Abstract available

  6. BENDARDAF R, Sharif-Askari FS, Sharif-Askari NS, Syrjanen K, et al
    Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.
    Anticancer Res. 2019;39:1953-1957.
    PubMed     Text format     Abstract available

  7. ALAGARATNAM S, Yang SY, Loizidou M, Fuller B, et al
    Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles.
    Anticancer Res. 2019;39:1705-1710.
    PubMed     Text format     Abstract available

    BMC Cancer

  8. DE MESQUITA GHA, Carvalho BJ, de Almeida Medeiros KA, Nii F, et al
    Intussusception reveals MUTYH-associated polyposis syndrome and colorectal cancer: a case report.
    BMC Cancer. 2019;19:324.
    PubMed     Text format     Abstract available

    Br J Surg

  9. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2019;106:728.
    PubMed     Text format    

    Clin Cancer Res

  10. SCHIRRIPA M, Biason P, Lonardi S, Pella N, et al
    Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization.
    Clin Cancer Res. 2019 Apr 9. pii: 1078-0432.CCR-19-0311.
    PubMed     Text format     Abstract available

  11. ANANDAPPA G, Lampis A, Cunningham D, Khan KH, et al
    MicroRNA 31-3p expression and benefit from anti-EGFR inhibitors in metastatic colorectal cancer patients enrolled in the prospective phase II PROSPECT-C trial.
    Clin Cancer Res. 2019 Apr 5. pii: 1078-0432.CCR-18-3769.
    PubMed     Text format     Abstract available

    Dis Colon Rectum

  12. FORD MM, Camp JV, Geiger TM, Hopkins MB, et al
    Assessing Hereditary Colorectal Cancer Referral Patterns to a Tertiary Care Center: A Novel Approach Using Geographic Information System Mapping.
    Dis Colon Rectum. 2019 Apr 5. doi: 10.1097/DCR.0000000000001398.
    PubMed     Text format     Abstract available

    Gastrointest Endosc

  13. EL-HALABI MM, Rex DK, Saito A, Eckert GJ, et al
    Defining adenoma detection rate benchmarks in average-risk male veterans.
    Gastrointest Endosc. 2019;89:137-143.
    PubMed     Text format     Abstract available

  14. TOLLIVORO TA, Jensen CD, Marks AR, Zhao WK, et al
    Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.
    Gastrointest Endosc. 2019;89:168-176.
    PubMed     Text format     Abstract available

  15. CADONI S, Hassan C, Frazzoni L, Ishaq S, et al
    Impact of water exchange colonoscopy on endoscopy room efficiency: a systematic review and meta-analysis.
    Gastrointest Endosc. 2019;89:159-167.
    PubMed     Text format     Abstract available

    Hum Pathol

  16. PYO JS, Park MJ, Kang DW
    The clinicopathological significance of micropapillary pattern in colorectal cancers.
    Hum Pathol. 2018;77:159-165.
    PubMed     Text format     Abstract available

  17. ZHANG M, Li G, Sun X, Ni S, et al
    MET amplification, expression, and exon 14 mutations in colorectal adenocarcinoma.
    Hum Pathol. 2018;77:108-115.
    PubMed     Text format     Abstract available

    Int J Cancer

  18. MINI E, Lapucci A, Perrone G, D'Aurizio R, et al
    RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32326.
    PubMed     Text format     Abstract available

  19. OSUMI H, Shinozaki E, Wakatsuki T, Suenaga M, et al
    Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32320.
    PubMed     Text format     Abstract available

    Int J Oncol

  20. BAO Y, Lu Y, Feng W, Yu H, et al
    COUPTFII promotes epithelialmesenchymal transition by inhibiting miR34a expression in colorectal cancer.
    Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4718.
    PubMed     Text format     Abstract available

    J Surg Oncol

  21. ANTONY P, Harnoss JC, Warschkow R, Schmied BM, et al
    Urgent surgery in colon cancer has no impact on survival.
    J Surg Oncol. 2019 Apr 12. doi: 10.1002/jso.25469.
    PubMed     Text format     Abstract available

    Lancet Oncol

    Building evidence-based treatment recommendations for advanced anal cancer: the time is now.
    Lancet Oncol. 2018;19:1009-1011.
    PubMed     Text format    

    Oncol Rep

  23. KITAGAWA H, Kitajima Y, Kai K, Komukai S, et al
    Predictive value of the ratio of 8hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer.
    Oncol Rep. 2019;41:3041-3050.
    PubMed     Text format     Abstract available

    PLoS One

  24. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Detrimental association between betel nut chewing and colorectal polyps in adult populations.
    PLoS One. 2018;13:e0206383.
    PubMed     Text format     Abstract available

  25. CAMPAYO M, Navarro A, Benitez JC, Santasusagna S, et al
    miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    PLoS One. 2018;13:e0206542.
    PubMed     Text format     Abstract available

  26. SHRIVASTAV M, Gounaris E, Khan MW, Ko J, et al
    Validation of near infrared fluorescence (NIRF) probes in vivo with dual laser NIRF endoscope.
    PLoS One. 2018;13:e0206568.
    PubMed     Text format     Abstract available

  27. KIRAGA L, Cheda L, Taciak B, Rozanska K, et al
    Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination.
    PLoS One. 2018;13:e0206706.
    PubMed     Text format     Abstract available

  28. CAMPOS NA, da Cunha MSB, Arruda SF
    Tucum-do-cerrado (Bactris setosa Mart.) modulates oxidative stress, inflammation, and apoptosis-related proteins in rats treated with azoxymethane.
    PLoS One. 2018;13:e0206670.
    PubMed     Text format     Abstract available

  29. LIU Z, Duan ZJ, Chang JY, Zhang ZF, et al
    Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression.
    PLoS One. 2019;14:e0215388.
    PubMed     Text format    

  30. LI X, Zhong Q, Luo D, Du Q, et al
    The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
    PLoS One. 2019;14:e0214611.
    PubMed     Text format     Abstract available

  31. KANG YJ, Smith M, Canfell K
    Anal cancer in high-income countries: Increasing burden of disease.
    PLoS One. 2018;13:e0205105.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.